In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Retractable Technologies, Inc.

http://www.retractable.com/

Latest From Retractable Technologies, Inc.

BD Has Paid Enough In False-Ad Suit, Appeals Court Says

Becton Dickinson won’t need to pay more to resolve a long-running false-advertising case, a federal appeals court has ruled in a split decision.

Advertising, Marketing & Sales Intellectual Property

Prevention/Innovation Key To Driving Down Hospital Infections

The US market for infection control and biosafety products will see strong growth ahead as hospitals continue the battle against health care-associated infections with innovative products and services designed to prevent needlesticks, nosocomial infections, and the spread of antibiotic-resistant organisms.

Medical Device Innovation

Boehringer Files Pradaxa Antidote, Could Lead To Reversible Novel Anticoagulant

Finishing off a rolling BLA, company believes that the specific antidote for its novel anticoagulant Pradaxa will be eligible for accelerated approval based on Phase I data in volunteers.

BioPharmaceutical Clinical Trials

Boehringer Files Pradaxa Antidote, Could Be First Reversible Novel Anticoagulant

Finishing off a rolling BLA, company believes that the specific antidote for its novel anticoagulant Pradaxa will be eligible for accelerated approval based on Phase I data in volunteers.

Clinical Trials Regulation
See All

Company Information

  • Industry
  • Medical Devices
UsernamePublicRestriction

Register